Evidence map›Paper›PMID 33320834›Full record

ArticleJCI insight2021

Vasopressin mediates fructose-induced metabolic syndrome by activating the V1b receptor.

Ana Andres-Hernando, Thomas J Jensen, Masanari Kuwabara, David J Orlicky, Christina Cicerchi, Nanxing Li, Carlos A Roncal-Jimenez, Gabriela E Garcia, Takuji Ishimoto, Paul S Maclean and 6 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. New Insight Into Male Infertility: Deviation From Basic Tenets of Life.Oxidative medicine and cellular longevity · 2026
    Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. A study on the early metabolic effects of salt and fructose consumption: the protective role of water.Hypertension research : official journal of the Japanese Society of Hypertension · 2024
    Article
  14. Article
  15. The Role of Uric Acid in Human Health: Insights from theJournal of personalized medicine · 2023
    Review
  16. The fructose survival hypothesis for obesity.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Review
  17. Review
  18. The damaging duo: Obesity and excess dietary salt contribute to hypertension and cardiovascular disease.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2023
    Review
  19. Fructose: A New Variable to Consider in SIADH and the Hyponatremia Associated With Long-Distance Running?American journal of kidney diseases : the official journal of the National Kidney Foundation · 2023
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 5 countries.

Ana Andres-HernandoDivision of Renal Diseases and Hypertension and.
Thomas J JensenDivision of Endocrine, Diabetes, and Metabolism, University of Colorado Denver, Aurora, Colorado, USA.
Masanari KuwabaraDivision of Renal Diseases and Hypertension and.
David J OrlickyDepartment of Pathology, University of Colorado School of Medicine, Aurora, Colorado, USA.
Christina CicerchiDivision of Renal Diseases and Hypertension and.
Nanxing LiDivision of Renal Diseases and Hypertension and.
Carlos A Roncal-JimenezDivision of Renal Diseases and Hypertension and.
Gabriela E GarciaDivision of Renal Diseases and Hypertension and.
Takuji IshimotoDepartment of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Paul S MacleanDivision of Endocrinology, Metabolism and Diabetes, University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado, USA.
Petter BjornstadDivision of Renal Diseases and Hypertension and.
Laura Gabriela Sanchez-LozadaDepartment of Nephrology, Instituto Nacional de Cardiología-Ignacio Chavez, Mexico City, Mexico.
Mehmet KanbayDepartment of Medicine, Division of Nephrology, Koc University School of Medicine, Istanbul, Turkey.
Takahiko NakagawaDepartment of Nephrology, Rakuwakai Otowa Hospital, Kyoto, Japan.
Richard J JohnsonDivision of Renal Diseases and Hypertension and.
Miguel A LanaspaDivision of Renal Diseases and Hypertension and.
Metabolism and Renal Physiology · FRUniversity of Colorado Denver · USInstituto Nacional de Cardiología · MXKoç University · TRNagoya University · JPRakuwakai Otowa Hospital · JPUniversity of Colorado Anschutz Medical Campus · US

Funding

PILOT STUDY--SUBSTRATE METABOLISM IN EXTREMELY LOW BIRTH WEIGHT INFANTSP30DK048520 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI JANINE A HIGGINS · 1995 to 2026
$32.6M
Central Hub for Kidney Precision MedicineU24DK114886 · NIDDK · UNIVERSITY OF WASHINGTON · PI Jonathan Himmelfarb, Matthias Kretzler · 2022 to 2026
$21.1M
TRAINING PROGRAM IN DIABETES, ENDOCRINOLOGY &METABOLISMT32DK007446 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI BESSESEN, DANIEL HOLLAND · 1986 to 2017
$5.6M
Targeting fructokinase, endogenous fructose production and purine degradation for the prevention and treatment of hereditary fructose intoleranceR01DK108859 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI Miguel Angel Lanaspa Garcia · 2016 to 2026
$2.4M
Dietary Salt has an Unrecognized Role in Modulating Energy Intake and Metabolic SyndromeR01DK108408 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI JOHNSON, RICHARD JOSEPH · 2016 to 2019
$1.6M
A Novel Role for Vasopressin in Fructose-Induced Metabolic SyndromeR01DK121496 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI LANASPA GARCIA, MIGUEL ANGEL · 2020 to 2023
$1.6M
Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes StudyK23DK116720 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI BJORNSTAD, PETTER · 2018 to 2022
$963k
NIDDK NIH HHS K23 DK116720NIDDK NIH HHS P30 DK048520NIDDK NIH HHS R01 DK108408NIDDK NIH HHS R01 DK108859NIDDK NIH HHS R01 DK121496NIDDK NIH HHS T32 DK007446NIDDK NIH HHS U24 DK114886
6 · The paper itself

Abstract

Subjects with obesity frequently have elevated serum vasopressin levels, noted by measuring the stable analog, copeptin. Vasopressin acts primarily to reabsorb water via urinary concentration. However, fat is also a source of metabolic water, raising the possibility that vasopressin might have a role in fat accumulation. Fructose has also been reported to stimulate vasopressin. Here, we tested the hypothesis that fructose-induced metabolic syndrome is mediated by vasopressin. Orally administered fructose, glucose, or high-fructose corn syrup increased vasopressin (copeptin) concentrations and was mediated by fructokinase, an enzyme specific for fructose metabolism. Suppressing vasopressin with hydration both prevented and ameliorated fructose-induced metabolic syndrome. The vasopressin effects were mediated by the vasopressin 1b receptor (V1bR), as V1bR-KO mice were completely protected, whereas V1a-KO mice paradoxically showed worse metabolic syndrome. The mechanism is likely mediated in part by de novo expression of V1bR in the liver that amplifies fructokinase expression in response to fructose. Thus, our studies document a role for vasopressin in water conservation via the accumulation of fat as a source of metabolic water. Clinically, they also suggest that increased water intake may be a beneficial way to both prevent or treat metabolic syndrome.

Indexed as

AnimalsDisease Models, AnimalDrinkingFructokinasesFructoseHep G2 CellsHumansLiverMaleMetabolic SyndromeMiceMice, Inbred C57BLMice, KnockoutReceptors, VasopressinVasopressinsfructokinaseFructokinasesFructoseReceptors, VasopressinVasopressinsCarbohydrate metabolismEndocrinologyMetabolismObesity

Identifiers

PMID33320834
PMCPMC7821599
OpenAlexW3113364790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.